X @The Wall Street Journal

Regulatory Approval - Regeneron Pharmaceuticals' Lynozyfic treatment receives accelerated approval from the Food and Drug Administration for specific multiple myeloma patients [1] Pharmaceutical Industry - The approval highlights advancements in blood cancer treatment [1]